X hits on this document

Word document

I.EXECUTIVE ORDERS - page 181 / 359

1722 views

0 shares

0 downloads

0 comments

181 / 359

pharmacist containing all the information required in Subsection C of this Section, except for the signature of the prescriber.
b.An individual practitioner may administer or provide directly a controlled substance listed in Schedule III, IV, or V without a prescription, in the course of his professional practice, subject to the provisions of Subsection E of this Section.
c.An institutional practitioner may administer or provide directly (but not prescribe) a controlled substance listed in Schedule III, IV, or V only pursuant to a written prescription signed by an individual practitioner, or pursuant to a facsimile of a written prescription or order for medication transmitted by the practitioner or the practitioner’s agent to the institutional pharmacist, or pursuant to an oral prescription made by an individual practitioner and promptly reduced to written form by the pharmacist (containing all information required in Subsection C of this Section except for the signature of the prescriber), or pursuant to an order for medication made by an individual practitioner which dispensed for immediate administration to the ultimate user in conformance with the requirements of Subsection E of this Section.
d.A prescription issued by a prescriber may be communicated to a pharmacist by an employee or agent of the prescriber.
e.Notwithstanding the requirements of this Subsection, a prescription for a controlled substance listed in Schedule III, IV, or V may be generated, signed, transmitted or received in electronic form, but not until permitted by the DEA, and then only in conformance with the rules established for such procedures.
2.Expiration Date of Prescriptions A prescription for a controlled substance listed in Schedule III, IV, or V shall expire six months after the date of issue, or following the acquisition of the number of refills authorized by the prescriber on the original prescription, whichever shall first occur. No pharmacist shall dispense any controlled substance pursuant to an expired prescription.
3.Refilling of Prescriptions. The prescriber may authorize the refilling of a prescription for a controlled substance listed in Schedule III, IV, or V by including specific refill instructions on the prescription prior to its issuance. The maximum number of refills the prescriber may authorize is five. In the absence of a specific refill instruction on the original prescription from the prescriber, the prescription shall not be refilled.

AUTHORITY NOTE:Promulgated in accordance with R.S. 40:972.

HISTORICAL NOTE:Promulgated by the Department of Health and Hospitals, Board of Pharmacy, LR 34:2149 (October 2008).

§2747.Dispensing Requirements

A.Location of Dispensing Activities. A pharmacist may dispense a prescription for a controlled substance pursuant to a valid prescription or order while in the usual course of his professional practice, but only within a prescription department in a pharmacy licensed by the board. A valid prescription or order is a prescription or order issued for a legitimate medical purpose by a practitioner authorized by law while acting in the usual course of his professional practice.

B.Prescriptions for Controlled Substances Listed in Schedule II

1.Oral Prescriptions. A pharmacist may accept and dispense an oral prescription from a prescribing practitioner, but only under the conditions described in, and in conformance with the requirements of, §2745.F.1.f of this Chapter.
2.Prescriptions Received by Facsimile Equipment
a.The facsimile equipment designated for the receipt of prescriptions shall be located within a prescription department in a pharmacy. The paper or other media used in the facsimile equipment designated for the receipt of prescriptions shall be non-fading and technically capable of providing a legible prescription.
b.A pharmacist shall not dispense a prescription based solely on a copy of the prescription received by facsimile, except under the circumstances described in §2745.F.1.b.i, ii or iii.
c.In the event the facsimile transmission does not clearly identify the prescriber’s office or other authorized location as the point of origin of the transmission, the pharmacist shall verify the authenticity of the prescription prior to dispensing the controlled substance.
3.Expiration Date. A pharmacist shall not dispense a prescription for a controlled substance listed in Schedule II more than six months after the date of issue of the prescription.
4.Completion of Prescription Form. In the event a pharmacist receives a prescription for a controlled substance listed in Schedule II lacking certain required information, the pharmacist may consult with the prescriber (but not the prescriber's agent) to clarify the prescriber's intent. Following a consultation with the prescriber and the appropriate documentation thereof on the prescription form:
a.A pharmacist may record changes to the following data elements on the prescription form:
i.patient's address;
ii.drug strength;
iii.quantity prescribed; or
iv.directions for use.
b.A pharmacist may add the following data elements on the prescription form:
i.patient's address;
ii.drug dosage form; or
iii.prescriber's DEA registration number; however,
c.a pharmacist shall never make changes to or add the following data elements on the prescription form:
i.patient's name;
ii.date of issue;
iii.drug name (except for generic interchange as permitted by law); or
iv.prescriber signature.
5.Partial Filling of Prescription
a.The partial filling of a prescription for a controlled substance listed in Schedule II is permissible, if the pharmacist is unable to supply the full quantity called for in a written (or emergency oral) prescription and he makes a notation of the quantity supplied on the face of the written prescription (or written record of the emergency oral prescription). The remaining portion of the prescription may

Louisiana Register   Vol. 34, No. 10   October 20, 2008

Document info
Document views1722
Page views1725
Page last viewedFri Dec 09 12:40:41 UTC 2016
Pages359
Paragraphs18243
Words293762

Comments